Pfizer, Genentech Target Roxane Over Generic Cancer Drug
Pfizer Inc., Genentech Inc. and Astellas Pharma Inc. unit OSI Pharmaceuticals LLC on Friday sued Roxane Laboratories Inc. in Delaware federal court over the generic-drug maker's bid for approval to market...To view the full article, register now.
Already a subscriber? Click here to view full article